4.0 Article

Investigation of the interactions between the EphB2 receptor and SNEW peptide variants

Journal

GROWTH FACTORS
Volume 32, Issue 6, Pages 236-246

Publisher

INFORMA HEALTHCARE
DOI: 10.3109/08977194.2014.985786

Keywords

EphB2 receptor; ephrin ligands; inhibitor design; molecular dynamics simulations; protein stability; protein dynamics

Funding

  1. National Cancer Institute, National Institutes of Health [HHSN261200800001E]
  2. CCR/NCI
  3. NIBIB/NIH Biomedical Engineering Summer Internship Program (BESIP)
  4. Hi-tech Research and Development Program of China [2008AA02Z311]
  5. Shanghai Natural Science Foundation [13ZR1402400]
  6. Shanghai Leading Academic Discipline Project [B111]

Ask authors/readers for more resources

EphB2 interacts with cell surface-bound ephrin ligands to relay bidirectional signals. Overexpression of the EphB2 receptor protein has been linked to different types of cancer. The SNEW (SNEWIQPRLPQH) peptide binds with high selectivity and moderate affinity to EphB2, inhibiting Eph-ephrin interactions by competing with ephrin ligands for the EphB2 high-affinity pocket. We used rigorous free energy perturbation (FEP) calculations to re-evaluate the binding interactions of SNEW peptide with the EphB2 receptor, followed by experimental testing of the computational results. Our results provide insight into dynamic interactions of EphB2 with SNEW peptide. While the first four residues of the SNEW peptide are already highly optimized, change of the C-terminal end of the peptide has the potential to improve SNEW-binding affinity. We identified a PXSPY motif that can be similarly aligned with several other EphB2-binding peptides.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Deep learning for drug repurposing: Methods, databases, and applications

Xiaoqin Pan, Xuan Lin, Dongsheng Cao, Xiangxiang Zeng, Philip S. Yu, Lifang He, Ruth Nussinov, Feixiong Cheng

Summary: This review introduces guidelines on utilizing deep learning methodologies and tools for drug repurposing, which is of great importance in drug development. The article summarizes the commonly used bioinformatics and pharmacogenomics databases for drug repurposing and discusses the recently developed sequence-based and graph-based representation approaches as well as state-of-the-art deep learning-based methods. The applications of drug repurposing in fighting the COVID-19 pandemic are presented, along with an outline of future challenges.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2022)

Review Multidisciplinary Sciences

How can same-gene mutations promote both cancer and developmental disorders?

Ruth Nussinov, Chung-Jung Tsai, Hyunbum Jang

Summary: The question of how the same gene mutations can lead to both cancer and neurodevelopmental disorders has always been puzzling. This article reviews the literature and proposes that factors such as cell type-specific expression of the mutant protein, timing of activation, and the absolute number of molecules involved play key roles in determining the pathological phenotypes.

SCIENCE ADVANCES (2022)

Review Biochemistry & Molecular Biology

Allostery, and how to define and measure signal transduction

Ruth Nussinov, Chung-Jung Tsai, Hyunbum Jang

Summary: This article discusses the concept of productive signaling, including its definition, measurement, and determining factors. It highlights the importance of understanding signal propagation in diseases like cancer and neurodevelopmental disorders. The authors propose a framework for investigating signal transduction by defining cellular processes, conducting experimental measurements, and utilizing computational AI algorithms.

BIOPHYSICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire

Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov

Summary: Bcr-Abl, a nonreceptor tyrosine kinase, plays a crucial role in leukemias, particularly chronic myeloid leukemia (CML). The fusion of Bcr and Abl leads to constitutive activation of Bcr-Abl. Oligomerization of Bcr-Abl is critical for its membrane clustering, MAPK signaling, and cell proliferation. Understanding the structural basis of Bcr-Abl oligomerization can guide the development of novel drugs targeting this process.

PROTEIN SCIENCE (2023)

Article Cell Biology

Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia

Chunyang Yi, Jiacheng He, Dan Huang, Yumiao Zhao, Chan Zhang, Xiyun Ye, Ying Huang, Ruth Nussinov, Junke Zheng, Mingyao Liu, Weiqiang Lu

Summary: Activation of the orphan GPCR GPR132 induces cell differentiation in acute myeloid leukemia (AML) and the natural product 8-gingerol is found to be a potential GPR132 agonist, promoting differentiation and reducing colony formation in AML cell lines.

CELL DEATH & DISEASE (2022)

Letter Oncology

Activation mechanisms of clinically distinct B-Raf V600E and V600K mutants

Mingzhen Zhang, Ryan Maloney, Yonglan Liu, Hyunbum Jang, Ruth Nussinov

CANCER COMMUNICATIONS (2023)

Review Cell Biology

Deep generative molecular design reshapes drug discovery

Xiangxiang Zeng, Fei Wang, Yuan Luo, Seung-Gu Kang, Jian Tang, Felice C. Lightstone, Evandro F. Fang, Wendy Cornell, Ruth Nussinov, Feixiong Cheng

Summary: The recent advances of AI and deep generative models in medicinal applications, specifically in drug discovery and development, have proven their utility. This review provides an updated and accessible guide for the computational drug discovery and development community, discussing classical and newly developed AI approaches. The theoretical frameworks for representing chemical and biological structures and their applications are described, along with the challenges and future directions of multimodal deep generative models for accelerating drug discovery.

CELL REPORTS MEDICINE (2022)

Article Chemistry, Multidisciplinary

Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor

Alix Troester, Michael DiPrima, Nathalie Jores, Denis Kudlinzki, Sridhar Sreeramulu, Santosh L. Gande, Verena Linhard, Damian Ludig, Alexander Schug, Krishna Saxena, Maria Reinecke, Stephanie Heinzlmeir, Matthias S. Leisegang, Jan Wollenhaupt, Frank Lennartz, Manfred S. Weiss, Bernhard Kuster, Giovanna Tosato, Harald Schwalbe

Summary: In this study, a series of derivatives of the EPHA2 inhibitor NVP-BHG712 and triazine-based compounds were synthesized and evaluated. Eight inhibitors showed high affinity for EPHA2. Testing in seven colon cancer cell lines revealed promising effects of some derivatives for the control of human colon carcinoma.

CHEMISTRY-A EUROPEAN JOURNAL (2023)

Review Pharmacology & Pharmacy

AlphaFold, allosteric, and orthosteric drug discovery: Ways forward

Ruth Nussinov, Mingzhen Zhang, Yonglan Liu, Hyunbum Jang

Summary: Drug discovery is a highly challenging and significant interdisciplinary aim. The success of AlphaFold, an AI-powered technology, has raised hopes for drug discovery, but its limitations need to be considered. Improving AlphaFold's performance in active state models can enhance the success rate of rational drug design.

DRUG DISCOVERY TODAY (2023)

Article Chemistry, Physical

Strategy toward Kinase-Selective Drug Discovery

Mingzhen Zhang, Yonglan Liu, Hyunbum Jang, Ruth Nussinov

Summary: Kinase drug selectivity is a challenge in cancer research. Researchers propose a protocol to identify unique geometric features in the drug pocket that can distinguish one kinase from others. They analyze the structural principles of kinase drug selectivity using experimental structures and artificial intelligence. The results show that there are binary units in the kinome that can distinguish kinases from each other.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2023)

Review Biophysics

Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK

Ruth Nussinov, Bengi Ruken Yavuz, M. Kaan Arici, Habibe Cansu Demirel, Mingzhen Zhang, Yonglan Liu, Chung-Jung Tsai, Hyunbum Jang, Nurcan Tuncbag

Summary: Neurodevelopmental disorders (NDDs) and cancer have similarities in terms of proteins, pathways, and mutations, but have different clinical symptoms. However, individuals with NDDs have a higher likelihood of developing cancer later on. This review explores how shared features can result in different medical conditions and why having an NDD first can increase the chances of malignancy.

BIOPHYSICAL REVIEWS (2023)

Article Chemistry, Medicinal

Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer

Alix Troster, Nathalie Jores, Konstantin S. Mineev, Sridhar Sreeramulu, Michael DiPrima, Giovanna Tosato, Harald Schwalbe

Summary: This concept paper describes the general strategies for EPHA2 inhibition with small molecules and summarizes the potential of targeting EPHA2 in CRC. EPHA2 plays a crucial role in the development and resistance mechanisms of CRC.

CHEMMEDCHEM (2023)

Article Genetics & Heredity

Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome

Bengi Ruken Yavuz, M. Kaan Arici, Habibe Cansu Demirel, Chung-Jung Tsai, Hyunbum Jang, Ruth Nussinov, Nurcan Tuncbag

Summary: Epidemiological studies show that individuals with neurodevelopmental disorders are more likely to develop certain types of cancer. While these disorders and cancer share proteins, pathways, and mutations, they differ in clinical outcomes. The key factor determining clinical outcome is signaling strength, with strong signaling promoting cell proliferation in cancer and moderate signaling affecting differentiation in neurodevelopmental disorders.

NPJ GENOMIC MEDICINE (2023)

Article Biochemistry & Molecular Biology

Cell phenotypes can be predicted from propensities of protein conformations

Ruth Nussinov, Yonglan Liu, Wengang Zhang, Hyunbum Jang

Summary: The propensities of protein conformations can predict cell function and suggest drug efficiency.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2023)

Review Biochemistry & Molecular Biology

Protein conformational ensembles in function: roles and mechanisms

Ruth Nussinov, Yonglan Liu, Wengang Zhang, Hyunbum Jang

Summary: The sequence-structure-function paradigm in molecular biology has been updated to include the concept of conformational ensembles, recognizing that proteins are dynamic and constantly transitioning between different conformational states. The number and stability of these states are crucial for protein function. Understanding conformational propensities is essential for studying diverse systems and can provide insights into the dynamics of protein ensembles in cells.

RSC CHEMICAL BIOLOGY (2023)

No Data Available